This year, PluriCon will bring together an intimate, curated group of ~100–120 key opinion leaders across stem cell engineering, organoids, and NAMs for actionable, data-driven discussions setting the stage for the next 20+ years of iPSC-based advanced therapies.
The event will kick off with an exclusive VIP Networking Event the evening of September 16th followed by technical presentations and roundtables on the 17th, concluding with a networking reception that evening.
We are thrilled to welcome Dr. Jeanne Loring as our keynote speaker this year, along with talks from United Therapeutics, the Terasaki Institute for Biomedical Innovation, and several other therapeutics, tools and technology developers, and esteemed academics.
